AKT1 and head and neck squamous cell carcinoma: Addition of KTN3379 and BYL719 in all three HNSCC cell lines led to greater inhibition of HER3, AKT, and S6 than the inhibition observed with single-drug treatment with either BYL719 or KTN3379 (Fig. 4A).